Citation Impact
Citing Papers
[6] Use of T7 RNA polymerase to direct expression of cloned genes
1990 Standout
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
CD64 Expression Distinguishes Monocyte-Derived and Conventional Dendritic Cells and Reveals Their Distinct Role during Intramuscular Immunization
2012
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
2019 Standout
Hypoxia, a Novel Inducer of Acute Phase Gene Expression in a Human Hepatoma Cell Line
1995
Head and neck squamous cell carcinoma
2020 Standout
The effect of biocides on proteins of Pseudomonas aeruginosa PAO bacteriophage F116
1996
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
2010
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
1988 Standout
Currently approved prophylactic HPV vaccines
2009
Prevalence and Determinants of Genital Infection with Papillomavirus, in Female and Male University Students in Busan, South Korea
2004
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase
1991 Standout
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Immune responses to human papillomavirus
2005
Epidemiology, Clinical Manifestations, and Recent Advances in Vaccination against Human Papillomavirus
2010
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
2011
HPV vaccine: Cervarix
2010
Assessment of Human Papillomavirus in Lung Tumor Tissue
2011
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
2013
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Clinical trials of human papillomavirus vaccines and beyond
2013
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
2011
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
2011
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
2015
Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men
2004
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
2015
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆
2009
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
New adjuvants for human vaccines
2010
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Alternative dosage schedules with HPV virus-like particle vaccines
2014
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
2019
Human papillomavirus and cervical cancer
2007 Standout
Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection
2007
Mammalian oxygen sensing and hypoxia inducible factor-1
1997 StandoutNobel
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa
2010
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
2011 Standout
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
2011 Standout
Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
2012
Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
2009
Chapter 11: HPV vaccines: Commercial Research & Development
2006
Oxygen regulated gene expression: Erythropoietin as a model system
1997 StandoutNobel
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions
2015
Efficacy of Human Papillomavirus Vaccines
2009
Vaccine adjuvants revisited
2007
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Pulmonary vaccine delivery
2007
The molecular landscape of head and neck cancer
2018 Standout
Role of adjuvants in modeling the immune response
2010
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years
2011
Iron metabolism in transgenic mice with hypoplastic anaemia due to incomplete deficiency of erythropoietin
1997 StandoutNobel
Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array© using HPV52-specific TaqMan© E6/E7 quantitative real-time PCR
2008
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins
2011
Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
2009
Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer
2011
TLR-based immune adjuvants
2010
Prophylactic DNA immunization against multiple papillomavirus types
2007
Identification of Hypoxically Inducible mRNAs in HeLa Cells Using Differential‐Display PCR
1996 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections
2010
Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations
2020
The science of adjuvants
2007
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
2009
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
2016
Worldwide burden of cancer attributable to HPV by site, country and HPV type
2017 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
2018
Human Papillomavirus and Cervical Cancer
2003 Standout
Synapsin II. Mapping of a domain in the NH2-terminal region which binds to small synaptic vesicles.
1990 StandoutNobel
Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: Implications for tonsil cancer precursor lesions
2014
The purification of eukaryotic polypeptides synthesized in Escherichia coli
1986
The potential of nanoparticles for the immunization against viral infections
2015
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
2017
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: A search for human papillomavirus
2013
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
2008
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
2009
Hidden Killers: Human Fungal Infections
2012 Standout
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
2011
Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
2011
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Brigitte Colau being referenced
Revised Sequence of Full-Length Complementary DNA Coding for Human α 1 -Antitrypsin
1984
Molecular Cloning, Sequencing, and Expression in Escherichia coli of Human Preprourokinase cDNA
1985
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
2006
The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra
2015
E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical Disease
2012
A Human Papilloma Virus Testing Algorithm Comprising a Combination of the L1 Broad-Spectrum SPF 10 PCR Assay and a Novel E6 High-Risk Multiplex Type-Specific Genotyping PCR Assay
2013
Detection and Genotyping of Human Rotavirus VP4 and VP7 Genes by Reverse Transcriptase PCR and Reverse Hybridization
2009
Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF 10 Line Probe Assay
2002
Construction and characterization of a Saccharomyces cerevisiae strain (RIT4376) expressing hepatitis B surface antigen.
1987
Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR
2006